NO974400L - Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan - Google Patents

Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Info

Publication number
NO974400L
NO974400L NO974400A NO974400A NO974400L NO 974400 L NO974400 L NO 974400L NO 974400 A NO974400 A NO 974400A NO 974400 A NO974400 A NO 974400A NO 974400 L NO974400 L NO 974400L
Authority
NO
Norway
Prior art keywords
benazeprilat
valsartan
formula
preparations containing
combination preparations
Prior art date
Application number
NO974400A
Other languages
English (en)
Norwegian (no)
Other versions
NO974400D0 (no
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO974400D0 publication Critical patent/NO974400D0/no
Publication of NO974400L publication Critical patent/NO974400L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO974400A 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan NO974400L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (2)

Publication Number Publication Date
NO974400D0 NO974400D0 (no) 1997-09-23
NO974400L true NO974400L (no) 1997-09-23

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974400A NO974400L (no) 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (cs)
JP (1) JPH11503139A (cs)
KR (1) KR19980703647A (cs)
CN (1) CN1181019A (cs)
AU (1) AU5399096A (cs)
BR (1) BR9604818A (cs)
CA (1) CA2214143A1 (cs)
CZ (1) CZ313897A3 (cs)
HU (1) HUP9801593A2 (cs)
MX (1) MX9707683A (cs)
NO (1) NO974400L (cs)
PL (1) PL322529A1 (cs)
SK (1) SK133897A3 (cs)
TR (1) TR199701121T1 (cs)
WO (1) WO1996031234A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835106A4 (en) * 1995-06-30 1998-09-30 Merck & Co Inc METHOD OF TREATING NEPHROPATHIES USING AN ACE INHIBITOR AND AN A II ANTAGONIST
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
CZ20023381A3 (cs) * 2000-04-12 2003-02-12 Novartis Ag Kombinované farmaceutické prostředky obsahující antagonistu AT1-receptoru nebo/a inhibitor HMG-CoA reduktázy nebo/a ACE inhibitor
DE60135560D1 (de) 2000-07-19 2008-10-09 Novartis Ag Valsartan salze
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
UY26893A1 (es) * 2000-08-22 2002-03-22 Boehringer Ingelheim Pharma Combinación farmacéutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversión de la angiotensina i
CA2432638A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
JP2006516020A (ja) * 2002-08-28 2006-06-15 キュリス インコーポレイテッド 慢性腎不全の治療におけるモルフォゲン及びａｃｅ阻害薬の共投与
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
EP2432452B1 (de) 2009-05-20 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische telmisartan-trinklösung
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
AU2015210898A1 (en) * 2014-01-31 2016-07-28 Janssen Pharmaceutica Nv Methods for the treatment and prevention of renal disorders and fatty liver disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2147875C1 (ru) * 1990-05-11 2000-04-27 Пфайзер Инк. Способ и композиция для снижения кровяного давления и лечения застойной сердечной недостаточности у млекопитающего
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
SK133897A3 (en) 1998-02-04
WO1996031234A1 (en) 1996-10-10
CN1181019A (zh) 1998-05-06
KR19980703647A (ko) 1998-12-05
EP0820302A1 (en) 1998-01-28
HUP9801593A2 (hu) 1999-01-28
BR9604818A (pt) 1998-06-09
MX9707683A (es) 1997-12-31
JPH11503139A (ja) 1999-03-23
NO974400D0 (no) 1997-09-23
CA2214143A1 (en) 1996-10-10
PL322529A1 (en) 1998-02-02
CZ313897A3 (cs) 1998-01-14
TR199701121T1 (xx) 1998-03-21
AU5399096A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
NO974400L (no) Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
GB9914486D0 (en) Medicaments
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
CA2216796A1 (en) Quinazoline derivatives
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
WO1996016981A3 (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AU3664401A (en) Platelet adp receptor inhibitors
RU94044677A (ru) Трехзамещенные фенильные производные, способ получения, фармацевтическая композиция
DE69705300D1 (de) Cyclopropylalkansäurederivate
DE69530081D1 (de) Gastrin- und cck-antagonisten
SE9504661D0 (sv) New compounds
ATE194335T1 (de) 4,5-diaryloxazol-derivate
WO1999026932A8 (en) By amidino group substituted heterocyclic derivatives and their use as anticoagulants
MX9704856A (es) Derivados de indazol sustituidos.
NO20001514L (no) Vitronectin-reseptor-antagonist